Overview
GHK-Cu (glycyl-L-histidyl-L-lysine:copper 2+) is a naturally occurring tripeptide first isolated from human plasma in 1973 by Loren Pickart. It has since been detected in saliva, urine, and cerebrospinal fluid, with plasma concentrations declining significantly with age — from approximately 200 ng/mL at age 20 to around 80 ng/mL at age 60. This age-related decline has made it a target of longevity and skin-aging research. With over 50 years of published literature, GHK-Cu has one of the stronger research bases among synthetic peptides. Studies have examined its role in wound healing, anti-inflammatory signaling, collagen and glycosaminoglycan synthesis, and gene expression modulation.
Mechanism
GHK-Cu operates through multiple pathways. It chelates copper(II) ions and delivers them to sites requiring copper-dependent enzymatic activity. It upregulates collagen and elastin synthesis, promotes antioxidant defense via SOD induction, and has been shown to modulate the expression of over 4,000 human genes in microarray studies — with a general pattern of resetting gene expression to a more youthful profile. It also activates tissue remodeling via matrix metalloproteinase induction.
Research Areas
Side Effects (Preclinical)
- – Generally well-tolerated in published studies
- – Topical: rare contact dermatitis at high concentrations
- – Parenteral: mild injection-site reactions in animal studies
Cautions
- – For research use only — not approved as a therapeutic agent
- – Topical cosmetic preparations are distinct from research-grade injectable formulations
- – Copper toxicity is theoretically possible at supraphysiological doses — no cases reported in literature at standard research doses
Menopause & Women's Health Relevance
Estrogen directly regulates collagen synthesis — when estrogen declines at menopause, skin collagen drops ~30% in the first five years. GHK-Cu is one of the most studied peptides for stimulating collagen and elastin gene expression, making it a key research target for post-menopausal skin and joint health.
What the research shows
GHK-Cu occupies an unusual position in peptide research: it is simultaneously used as a cosmetic ingredient (listed as “Tripeptide-1” in INCI nomenclature) and studied for systemic effects at injectable doses. The cosmetic and injectable research literatures are largely separate.
Loren Pickart’s work over five decades remains the foundational literature for GHK-Cu, with particularly interesting findings around its broad gene-expression effects — the 2015 meta-analysis of microarray data suggested the peptide influences pathways from inflammation to circadian regulation.
References
- GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration — Pickart L et al. (2015)
- GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes — Pickart L et al. (2012)